Cargando…
Use of sildenafil or other phosphodiesterase inhibitors and risk of melanoma
BACKGROUND: Phosphodiesterase 5A inhibitors (PDEIs), a common treatment for erectile dysfunction, were recently linked to an increased risk of melanoma. METHODS: We conducted two parallel case–control studies, using the Danish Nationwide Health Registries (DNHR) and the Kaiser Permanente Northern Ca...
Autores principales: | Pottegård, Anton, Schmidt, Sigrún Alba Johannesdottir, Olesen, Anne Braae, Achacoso, Ninah, Van Den Eeden, Stephen K, Hallas, Jesper, Sørensen, Henrik Toft, Friis, Søren, Habel, Laurel A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5046205/ https://www.ncbi.nlm.nih.gov/pubmed/27529513 http://dx.doi.org/10.1038/bjc.2016.248 |
Ejemplares similares
-
Data Resource Profile: The Danish National Prescription Registry
por: Pottegård, Anton, et al.
Publicado: (2017) -
Association of Hydrochlorothiazide Use and Risk of Malignant Melanoma
por: Pottegård, Anton, et al.
Publicado: (2018) -
Obesity in young men, and individual and combined risks of type 2 diabetes, cardiovascular morbidity and death before 55 years of age: a Danish 33-year follow-up study
por: Schmidt, Morten, et al.
Publicado: (2013) -
Time for integrating clinical, lifestyle and molecular data to predict drug responses — Authors' reply
por: Pottegård, Anton, et al.
Publicado: (2016) -
Identification of Associations Between Prescribed Medications and Cancer: A Nationwide Screening Study
por: Pottegård, Anton, et al.
Publicado: (2016)